A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors

Conditions

• Ocular Tumor

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Intalight Dream OCT — DIAGNOSTIC_TEST
  This is a next-generation swept-source device that has a faster imaging speed and higher sensitivity than the previous generation of frequency-domain OCT devices, which serve as the current standard of care devices.
• Heidelberg Spectralis OCT — DIAGNOSTIC_TEST
  This is the standard of care for optical imaging.

Study Details

The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer

Key Dates

Start date

Feb 27, 2026

Status verified

May 2026

Primary completion

Feb 27, 2028

Completion

Feb 27, 2028

Study Design

Enrollment

60 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Arms

• Experimental: Participants with Ocular Tumor
  Participants will have at least 1 eye that has an intraocular or ocular surface tumor.

Primary Outcome Measure

Image quality for participants [ Time Frame: Up to 1 year ]

Central Contacts

• Jasmine Francis, MD
  212-639-7266
  [email protected]
• David Abramson, MD
  212-639-7232
  [email protected]

Locations (7)

Find similar trials in Basking Ridge, NJ

Related Studies

• Intraoperative OCT Guidance of Intraocular Surgery II
  Recruiting · Duke University · Durham, North Carolina